Managing aHUS: A Multidisciplinary Team Approach to Thrombotic Microangiopathy
Thrombotic microangiopathies are rare, life-threatening diseases whose treatment involves multiple physicians from different specialties. Atypical hemolytic uremic syndrome (aHUS) is a form of thrombotic microangiopathy characterized by the formation of blood clots in the body’s small blood vessels, with symptoms often first appearing in childhood. Severe forms of aHUS can lead to chronic kidney disease and kidney failure. Because symptoms are often non-specific (including paleness, nausea, vomiting, fatigue, drowsiness, high blood pressure, and swelling), diagnosis of aHUS can be complex and can impact the success of pediatric kidney transplants.
Hosted following National Pediatric Transplant Awareness Week, NICHQ invites pediatricians and specialists to continue the conversation by widening their understanding of the clinical presentation of aHUS, learn more about the presentation and treatment, and discover how a team approach can successfully manage aHUS.
Webinar Objectives:
-
Understand the clinical presentation of aHUS
-
Understand the pathophysiology of aHUS and the genetic background of the disease
-
Multidisciplinary Team approach to the management of aHUS
1 Hour
Jean M. Francis, MD, Associate Professor of Medicine at Boston University School of Medicine